End-stage renal failure due to amyloidosis: Outcomes in 490 ANZDATA registry cases

Nephrology Dialysis Transplantation

Volumn 28, Issue 2, 2013, Pages 455-461

  Tang, Wen ^a,b,c   McDonald, Stephen P ^a,d   Hawley, Carmel M ^a,c   Badve, Sunil V ^a,c   Boudville, Neil ^a,e   Brown, Fiona G ^a,f   Clayton, Philip A ^a,g   Campbell, Scott B ^a,c   De Zoysa, Janak R ^a,h   Johnson, David W ^a,c  

^a ANZDATA Registry   (Australia)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f MONASH MEDICAL CENTRE   (Australia)

^g ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^h NORTH SHORE HOSPITAL   (New Zealand)

Author keywords

amyloidosis; end stage renal failure; outcomes; recurrence; renal transplantation

Indexed keywords

ADOLESCENT; ADULT; AGED; AMYLOIDOSIS; ARTICLE; AUSTRALIA; CAUSE OF DEATH; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE REGISTRY; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEMODIALYSIS; HUMAN; INFANT; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); NEW ZEALAND; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RECURRENT DISEASE; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; AUSTRALIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEW ZEALAND; PROGNOSIS; RECURRENCE; REGISTRIES; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84874514513     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs492     Document Type: Article

References (20)

1. Dember LM. Amyloidosis-associated kidney disease. J Am Soc Nephrol 2006; 17: 3458-3471 (Pubitemid 44865288)
2. Eirin A, Irazabal MV, Gertz MA et al. Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascularlimited deposition in the kidney. Nephrol Dial Transplant 2012; 27: 1097-1101
3. Haq A, Hussain S, Meskat B et al. Complications of renal transplantation in patients with amyloidosis. Transplant Proc 2007; 39: 120-124 (Pubitemid 46175942)
4. Nishi S, Alchi B, Imai N et al. New advances in renal amyloidosis. Clin Exp Nephrol 2008; 12: 93-101
5. Bollee G, Guery B, Joly D et al. Presentation and outcome of patients with systemic amyloidosis undergoing dialysis. Clin J Am Soc Nephrol 2008; 3: 375-381
6. Gertz MA, Kyle RA, O'Fallon WM. Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients. Arch Intern Med 1992; 152: 2245-2250
7. Kuroda T, Tanabe N, Sato H et al. Outcome of patients with reactive amyloidosis associated with rheumatoid arthritis in dialysis treatment. Rheumatol Int 2006; 26: 1147-1153 (Pubitemid 44450853)
8. Sengul S, Arat Z, Ozdemir FN. Renal amyloidosis is associated with increased mortality in hemodialysis patients. Artif Organs 2004; 28: 846-852 (Pubitemid 39159157)
9. Ylinen K, Gronhagen-Riska C, Honkanen E et al. Outcome of patients with secondary amyloidosis in dialysis treatment. Nephrol Dial Transplant 1992; 7: 908-912
10. Pinney JH, Lachmann HJ, Bansi L et al. Outcome in renal AL amyloidosis after chemotherapy. J Clin Oncol 2011; 29: 674-681
11. Bergesio F, Ciciani AM, Manganaro M et al. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome. Nephrol Dial Transplant 2008; 23: 941-951
12. Gertz MA, Leung N, Lacy MQ et al. Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney. Nephrol Dial Transplant 2009; 24: 3132-3137
13. Ozdemir BH, Ozdemir FN, Sezer S et al. Among therapy modalities of end-stage renal disease, renal transplantation improves survival in patients with amyloidosis. Transplant Proc 2006; 38: 432-434
14. Sherif AM, Refaie AF, Sobh MA et al. Long-term outcome of live donor kidney transplantation for renal amyloidosis. Am J Kidney Dis 2003; 42: 370-375 (Pubitemid 36944447)
15. Keven K, Sengul S, Kutlay S et al. Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience. Transplant Proc 2004; 36: 2632-2634 (Pubitemid 40036797)
16. Herrmann SM, Gertz MA, Stegall MD et al. Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation. Nephrol Dial Transplant 2011; 26: 2032-2036
17. Pasternack A, Ahonen J, Kuhlback B. Renal transplantation in 45 patients with amyloidosis. Transplantation 1986; 42: 598-601 (Pubitemid 17210290)
18. Kofman T, Grimbert P, Canoui-Poitrine F et al. Renal transplantation in patients with AA amyloidosis nephropathy: results from a French multicenter study. Am J Transplant 2011; 11: 2423-2431
19. Ronco P, Aucouturier P. Renal involvement in AL amyloidosis: the facts, the promise and the hope. Nephrol Dial Transplant 2009; 24: 2967-2969
20. Martinez-Vea A, Garcia C, Carreras M et al. End-stage renal disease in systemic amyloidosis: clinical course and outcome on dialysis. Am J Nephrol 1990; 10: 283-289 (Pubitemid 20317739)